Point about age and new anti coagulation agents Since the majority of atrial fib patients are over 70 and therefore are at risk for renal dysfunction, Eliquis will have an advantage as it has lower renal excretion percentage than both Pradaxa and Xarelto.
Market Data 
Markets 
AI
